http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014079954-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7ef609496551877998971a05fd281cd6 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57434 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate | 2013-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b956d30bd90dc42546e7b4386442b83 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_118c36ea208f9303ce11e1de2c197539 |
| publicationDate | 2014-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2014079954-A1 |
| titleOfInvention | Methods of diagnosing and therapeutic agents for use in the treatment of cancer |
| abstract | The present invention relates to the use of at least one subunit of PA28 selected from PA28α (PSME1) and PA28β (PSME2), which is over-expressed in prostate cancer tissue, as a marker suitable for diagnostic test for prostate cancer, and to therapeutic agents specific for at least one subunit of PA28 selected from PA28α (PSME1) and PA28β (PSME2) for use in the treatment of prostate cancer. |
| priorityDate | 2012-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 48.